PDE10A and schizophrenia: For example, clinical PET studies clearly showed a pathological loss of striatal PDE10A in Huntington’s disease but indicated that the expression of PDE10A is not altered in schizophrenia leading to a discussion on the involvement of the PDE10A protein in schizophrenia.